Treg activation during allograft tolerance induction requires mitochondrion-induced TGF-β1 in type 1 conventional dendritic cells
Journal of Clinical Investigation · 16.09.2025 · 135 (18)
DOI: 10.1172/jci178960 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 10.07.2025. Verfasst von Samantha L Schroth und 10 weiteren Autor:innen. Beteiligte Einrichtung: Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Dendritic Cells, Transforming Growth Factor beta1, Transplantation Tolerance. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIAID NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
The role of conventional type 1 DCs (cDC1s) in tolerance induction to solid organ allografts is unknown and important for strategies that seek to prolong allograft viability. Using a murine model deficient in cDC1s, we report cDC1s are required for donor antigen and costimulation blockade (DST + CoB) tolerance induction and survival of cardiac allografts. cDC1 deficiency led to decreases in CD4 + CD25 + FoxP3 + T cells within allograft and spleen tissue of transplant recipients, and this was found to be antigen specific. Donor antigen stimulation induced TGF-β1 expression in both in vivo cDC1s and in vitro Flt3L-derived cDC1s. Genetic deletion of TGF- β 1 in cDC1s prevented induction of antigen-specific CD4 + CD25 + FoxP3 + T cells and was associated with cardiac allograft rejection. In parallel, single-cell RNA sequencing and metabolic analysis revealed upregulation of cDC1 mitochondrial metabolic signatures after in vivo exposure to DST + CoB. Genetic inactivation of cDC1 mitochondrial metabolism reduced expression of cDC1 TGF-β1, decreased antigen-specific Treg populations, and impaired allograft tolerance. Taken together, our findings implicate cDC1s in strategies to preserve solid organ allografts and also implicate mitochondrial metabolism of cDC1s as a molecular mechanism to enhance the generation of antigen-specific CD4 + CD25 + FoxP3 + T cells through TGF-β1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
- State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.
- Center for Human Immunbiology, and.
- Department of Pathology, Feinberg School of Medicine, Chicago, Illinois, USA.
- Comprehensive Transplant Center, Feinberg School of Medicine, Chicago, Illinois, USA.
- Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, Illinois, USA.
Förderung
- NHLBI NIH HHS
- NIAID NIH HHS
- NCI NIH HHS
- NIGMS NIH HHS
- NHLBI Division of Intramural Research
Zitieren
APA
Schroth, S. L., Zhang, L., Jones, R. T., Glinton, K., Mani, N. L., Inui, H., Davidson, J. T., Weinberg, S. E., Chandel, N. S., Alegre, M. L., & Thorp, E. B. (2025). Treg activation during allograft tolerance induction requires mitochondrion-induced TGF-β1 in type 1 conventional dendritic cells. Journal of Clinical Investigation, 135(18). https://doi.org/10.1172/jci178960
Vancouver
Schroth SL, Zhang L, Jones RT, Glinton K, Mani NL, Inui H, et al. Treg activation during allograft tolerance induction requires mitochondrion-induced TGF-β1 in type 1 conventional dendritic cells. Journal of Clinical Investigation. 2025;135(18). doi:10.1172/jci178960
BibTeX
@article{Schroth2025,
author = {Schroth, Samantha L and Zhang, Lei and Jones, Rebecca Tl and Glinton, Kristofor and Mani, Nikita L and Inui, Hiroyasu and Davidson, Jesse T and Weinberg, Samuel E and Chandel, Navdeep S and Alegre, Maria-Luisa and Thorp, Edward B},
title = {Treg activation during allograft tolerance induction requires mitochondrion-induced TGF-β1 in type 1 conventional dendritic cells},
journal = {Journal of Clinical Investigation},
year = {2025},
volume = {135},
number = {18},
doi = {10.1172/jci178960}
}
EUVIMED